Beginning Wednesday, October 3, pharmacies will have to report any Schedule V drug requiring a prescription and any naloxone dispensed to the Prescription Monitoring Program. The change is the result of a Board of Pharmacy final rule published in the VA Register.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.